Clinical trial
Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
NCT00224809 · Baylor Research Institute, Other · Completed
Key facts
| NCT number | NCT00224809 |
|---|---|
| Title | Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation |
| Official title | Functional Mitral Regurgitation in STICH |
| Lead sponsor | Baylor Research Institute, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases, Coronary Disease |
| Intervention type | Drug, Procedure |
| Interventions | Angiotensin-Converting Enzyme Inhibitors, Coronary Artery Bypass Graft, Angiotensin Receptor Blockers, Spironolactone, Aspirin, Clopidogrel, Surgical Ventricular Restoration |
| Enrollment | 250 |
| Start date | Sep 1, 2002 |
| Completion | May 1, 2007 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 19, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: